AG
RPTX

Algert Global’s Repare Therapeutics RPTX Stock Holding History

Algert Global’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,710
Closed -$15K – 1311
2024
Q4 		$15K Buy
+11,710
New +$34.9K ﹤0.01% 1152
2023
Q4 		– Sell
-30,749
Closed -$371K – 1248
2023
Q3 		$371K Hold
30,749
– – 0.02% 833
2023
Q2 		$325K Hold
30,749
– – 0.01% 891
2023
Q1 		$303K Buy
30,749
+2,394
+8% +$27.5K 0.01% 946
2022
Q4 		$417K Hold
28,355
– – 0.02% 864
2022
Q3 		$344K Buy
+28,355
New +$365K 0.02% 914

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Algert Global's RPTX Position: Q1 2025 in Review

Algert Global sold out of Repare Therapeutics (RPTX) in Q1 2025, closing a stake of 11,710 shares — an estimated $15K sold.

Algert Global first reported a position in RPTX in Q3 2022 and held it in 6 quarters. The position peaked at $417K in Q4 2022. 50 funds tracked by Wall St. Rank hold RPTX as of Q1 2025.

  • Algert Global reported no remaining Repare Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Algert Global sold 11,710 Repare Therapeutics shares in Q1 2025, an estimated $15K.
  • Algert Global first reported a position in Repare Therapeutics in Q3 2022 and held it in 6 quarters.
  • Algert Global's Repare Therapeutics position peaked at $417K in Q4 2022.
  • 50 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2025.

Based on Algert Global's 13F filing for Q1 2025, filed 13 May 2025.